Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daria, Wilczyńska"'
Autor:
Ewa Szwejser-Zawislak, Mieszko M. Wilk, Piotr Piszczek, Justyna Krawczyk, Daria Wilczyńska, Daniela Hozbor
Publikováno v:
Vaccines, Vol 11, Iss 1, p 1 (2022)
After the pertussis vaccine had been introduced in the 1940s and was shown to be very successful in reducing the morbidity and mortality associated with the disease, the possibility of improving both vaccine composition and vaccination schedules has
Externí odkaz:
https://doaj.org/article/9e955bc82fee4c48a63c7b710d101125
Autor:
Ewa Szwejser-Zawislak, Mieszko M. Wilk, Piotr Piszczek, Justyna Krawczyk, Daria Wilczyńska, Daniela Hozbor
After the pertussis vaccine had been introduced in the 1940s and was shown to be very successful in reducing the morbidity and mortality associated with the disease, the possibility of improving both vaccine composition and vaccination schedules has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9727cacd62fcc139226d22f16f0fa6
https://ruj.uj.edu.pl/xmlui/handle/item/306629
https://ruj.uj.edu.pl/xmlui/handle/item/306629
Autor:
Karolina Pytka, Adrian Newman-Tancredi, Gniewomir Latacz, Joanna Sniecikowska, Anna Partyka, Anna Więckowska, Adam Bucki, Anna Wesołowska, Maciej Pawłowski, Magdalena Jastrzębska-Więsek, Monika Głuch-Lutwin, Elżbieta Wyska, Daria Wilczyńska, Agata Siwek, Katarzyna Przejczowska-Pomierny, Marcin Kołaczkowski
Publikováno v:
Journal of Medicinal Chemistry
Novel 1-(1-benzoylpiperidin-4-yl)methanamine derivatives with high affinity and selectivity for serotonin 5-HT1A receptors were obtained and tested in four functional assays: ERK1/2 phosphorylation, adenylyl cyclase inhibition, calcium mobilization,
Autor:
Annamaria Lubelska, Anna Wesołowska, Daria Wilczyńska, Magdalena Jastrzębska-Więsek, Anna Partyka, Katarzyna Kamińska, Małgorzata Anna Marć, Małgorzata Więcek, Gniewomir Latacz, Katarzyna Kieć-Kononowicz, Magdalena Kotańska, Jadwiga Handzlik, Grzegorz Satała
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 14, p 3420 (2019)
Volume 20
Issue 14
International Journal of Molecular Sciences, Vol 20, Iss 14, p 3420 (2019)
Volume 20
Issue 14
Among serotonin receptors, the 5-HT6 subtype is the most controversial and the least known in the field of molecular mechanisms. The 5-HT6R ligands can be pivotal for innovative treatment of cognitive impairment, but none has reached pharmacological
Autor:
Joanna, Sniecikowska, Monika, Gluch-Lutwin, Adam, Bucki, Anna, Więckowska, Agata, Siwek, Magdalena, Jastrzebska-Wiesek, Anna, Partyka, Daria, Wilczyńska, Karolina, Pytka, Krzysztof, Pociecha, Agnieszka, Cios, Elżbieta, Wyska, Anna, Wesołowska, Maciej, Pawłowski, Mark A, Varney, Adrian, Newman-Tancredi, Marcin, Kolaczkowski
Publikováno v:
Journal of medicinal chemistry. 62(5)
Novel 1-(1-benzoylpiperidin-4-yl)methanamine derivatives were designed as "biased agonists" of serotonin 5-HT
Autor:
Krzysztof Pociecha, Maciej Pawłowski, Daria Wilczyńska, Anna Wesołowska, Elżbieta Wyska, Karolina Pytka, Monika Głuch-Lutwin, Anna Partyka, Agata Siwek, Joanna Sniecikowska, Marcin Kołaczkowski, Adrian Newman-Tancredi, Adam Bucki, Agnieszka Cios, Mark A. Varney, Anna Więckowska, Magdalena Jastrzębska-Więsek
Novel 1-(1-benzoylpiperidin-4-yl)methanamine derivatives were designed as “biased agonists” of serotonin 5-HT1A receptors. The compounds were tested in signal transduction assays (ERK1/2 phosphorylation, cAMP inhibition, Ca2+ mobilization, and β
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2f9ff7c9dab9ea567c08af854d9ab0a
https://ruj.uj.edu.pl/xmlui/handle/item/145481
https://ruj.uj.edu.pl/xmlui/handle/item/145481
Autor:
Dorota Łażewska, Gniewomir Latacz, Daria Wilczyńska, Katarzyna Kieć-Kononowicz, Małgorzata Anna Marć, Annamaria Lubelska, Rafał Kurczab, Agata Doroz-Płonka, Anna Partyka, Magdalena Kotańska, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Jadwiga Handzlik
Publikováno v:
Molecules
Volume 24
Issue 24
Volume 24
Issue 24
Though the 5-HT6 serotonin receptor is an important target giving both agonists and antagonists similar therapeutic potency in the treatment of topic CNS-diseases, no 5-HT6R ligand has reached the pharmaceutical market yet due to the too narrow chemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc429ee7d18d41ff431b5945de7dd78c
https://ruj.uj.edu.pl/xmlui/handle/item/256650
https://ruj.uj.edu.pl/xmlui/handle/item/256650